Produktbild
Emily P. (Hrsg.) Wen

Vaccine Development and Manufacturing

Ebook (PDF Format)

Invaluable reference on how to produce a vaccine-from beginning to end Vaccine production is a major unit of many pharmaceutical companies. With several biotechnology companies involved in developing new types of vaccines, tremendous advances are been observed continually in all aspects of vaccine manufacturing. Novel adjuvants discovered in recent years have shown great promises in human clinical trials by helping elicit stronger immune response and provide durable memory effects. New concepts in facility designs have enabled multiple use of the same facility. Vaccine Development and Manufacturing serves as a reference on all aspects of vacc… Mehr

CHF 119.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails


Weitere Autoren: Ellis, Ronald (Hrsg.) / Pujar, Narahari S. (Hrsg.)
  • ISBN: 978-1-118-87092-1
  • EAN: 9781118870921
  • Produktnummer: 17060282
  • Verlag: Wiley
  • Sprache: Englisch
  • Erscheinungsjahr: 2014
  • Seitenangabe: 456 S.
  • Plattform: PDF
  • Masse: 4'732 KB

Über den Autor


EMILY P. WEN, PhD, is currently a Research Fellow at the Merck Research Laboratory in the department of Vaccine Process Development. Dr. Wen has led process developments for several major vaccine products from Phase I to Phase III clinical trials, including vaccines against hepatitis B, Haemophilus influenzae type b, Pneumococcal, Meningococcal, and Group B Streptococcus. RONALD ELLIS, PhD, is Chief Technology Officer at FutuRx Ltd in Israel. Dr. Ellis has more than 30 years of industry experience in line and senior management in many companies, including roles as project leader and champion of projects that resulted in five licensed vaccines which accrue 6;$4B in annual sales. He is the founding and incumbent Editor-in-Chief of the MedLine-/PubMed-indexed journal Human Vaccines & Immunotherapeutics. NARAHARI S. PUJAR, PhD, MBA, is currently an Executive Director and Integrated Product Leader in the Vaccine Business Line at Merck & Co., Inc. Dr. Pujar has contributed to a variety of vaccines and biologics products and product candidates. He is an active member of the American Chemical Society and was the past chair of the Division of Biochemical Technology.

1 weiteres Werk von Emily P. (Hrsg.) Wen:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.